Livzon Pharmaceutical Group Inc.

Sembol: 000513.SZ

SHZ

38.98

CNY

Bugünkü piyasa fiyatı

18.4135
F/K Oranı
0.4788
PEG Oranı
31.91B
MRK Kapağı
0.04%
DIV Verimi

Livzon Pharmaceutical Group Inc. (000513-SZ) Finansal Tablolar

Download

Yıllık Üç Aylık

Doğrusal Günlük

Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Livzon Pharmaceutical Group Inc. (000513.SZ). Şirketin geliri 4121.024 M ortalamasını gösterir ki bu da 0.105 % gowth'dur. Tüm dönem için ortalama brüt kar 2439.281 M olup 0.139 % dir. Ortalama brüt kar oranı 0.493 %dır. Şirketin geçen yılki performansı için net gelir artışı 0.023 % olup 0.699 % %'ne eşittir. tüm şirket geçmişi için ortalama.,

Yıllık Üç Aylık

10Y 20Y 30Y 40Y

Bilanço

Livzon Pharmaceutical Group Inc.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam 0 olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin 0.007 olduğu görülür. Dönen varlıklar alanında, 000513.SZ raporlama para birimi cinsinden 17266.175 değerini gösterir. Bu varlıkların önemli bir kısmı, tam olarak 11407.516, nakit ve kısa vadeli yatırımlarda tutulmaktadır. Bu bölüm, geçen yılın verileriyle yan yana getirildiğinde 0.084% oranında bir değişim göstermektedir. Şirketin uzun vadeli yatırımları, odak noktası olmamakla birlikte, raporlama para biriminde 1680.87 seviyesindedir. Bu, şirketin stratejik değişimlerini yansıtan son raporlama dönemine göre 3.113%'lik bir farka işaret etmektedir. Şirketin borç profili, raporlama para biriminde 1612.773 uzun vadeli toplam borcu göstermektedir. Bu rakam, yıldan yıla 0.392%'lik bir değişimi ifade etmektedir. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde 14042.495 olarak değerlenir. Bu açıdan yıldan yıla değişim 0.012%'dir. Şirketin mali tablolarına daha derinlemesine bakıldığında ek ayrıntılar ortaya çıkmaktadır. Net alacaklar 3648.366 değerinde, envanter 2060.65 değerinde ve varsa şerefiye 124.91 değerindedir. Varsa, toplam maddi olmayan duran varlıklar 714.17 ile değerlenir.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
balance-sheet.row.cash-and-short-term-investments	43995.67	11407.5	10519.4	9329.1	9979.7	8872.6	8603.9	7424.5	2067.9	804.9	722.1	772.4	1280.7	1492.1	921.8	637.4	662	730.8	421	200	418.6	484.5	312.2	248.8	120.7	152.5	44.9	76.3	90.3	42.8	62.1	51.4	80.1
balance-sheet.row.short-term-investments	333.39	81.8	108.1	182.8	26	17.2	15.9	8.7	6	6.6	6.4	11.3	59.3	44.3	57.9	48.9	121.8	448.1	137.1	70.5	115.1	60.5	16.9	16	10.7	0	0	0	1.3	5.7	11.2	0	0
balance-sheet.row.net-receivables	16280.25	3648.4	4285.6	3622.8	3108.6	2703.5	2630.3	2698.5	2113.9	1856.7	1648.4	1606.2	1199.8	1036	827.8	885.8	624.9	546.5	449.1	404.4	414.4	390.1	154.8	205.6	31.8	11.5	11.1	32.1	55.3	35	21.8	17.3	19.2
balance-sheet.row.inventory	8476.78	2060.7	2045.3	1663.2	1487.8	1168.9	1117	1102.6	1099.2	983.9	847.5	641.6	546.5	424.4	450.2	339.3	346.1	325.4	281.2	238.9	212.6	188	199.3	197.6	209.1	198.6	221	223.9	156.5	175.5	118.9	150.8	140
balance-sheet.row.other-current-assets	603.22	149.6	136.9	57.9	51.3	128.3	120.5	124.3	689.7	-67.6	-52.1	-39.5	-53	-44.5	-44.1	-20.9	-23.1	-16.6	5	0.9	0.1	0.5	309	259.8	433	460.7	535.9	474.8	438.8	356.5	300.4	298.6	202.1
balance-sheet.row.total-current-assets	69355.92	17266.2	16987.3	14673.1	14627.4	12873.2	12471.7	11349.9	5970.8	3577.9	3165.9	2980.7	2973.9	2908	2155.7	1841.6	1609.8	1586.1	1156.2	844.2	1045.8	1063.1	975.3	911.7	794.6	823.3	813	807.1	741	609.8	503.1	518	441.4
balance-sheet.row.property-plant-equipment-net	18589.52	4733.9	4591.9	4238.9	3707.1	3393.6	3402.1	3391.5	3542.7	3671.1	3505.4	3059.8	2157.7	1241.9	1147	928.1	963.3	1007.9	1037	1024.4	860.6	677.5	663.1	593.2	587.2	578.3	558.8	514.7	457.3	388.6	303.9	235.1	134.3
balance-sheet.row.goodwill	499.65	124.9	103	103	103	103	103	103	103	103	103	103	103	103	103	103	103	67.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	2867.53	714.2	826.4	834.8	487.8	378.1	325.3	289.1	313.7	272.7	258.3	224.5	206.6	171.9	168.1	153.6	158.4	156.1	136.9	117.3	122.4	108.3	109	73	58.4	36.7	28.5	8.1	5.7	4.5	3	0	0
balance-sheet.row.goodwill-and-intangible-assets	3367.17	839.1	929.4	937.8	590.9	481.1	428.4	392.2	416.8	375.8	361.3	327.6	309.7	274.9	271.1	256.7	261.4	223.3	136.9	117.3	122.4	108.3	109	73	58.4	36.7	28.5	8.1	5.7	4.5	3	0	0
balance-sheet.row.long-term-investments	6491.32	1680.9	1630.1	1512.1	962.1	634	579.9	277.4	232.4	241.9	172.8	122.5	72.3	83.4	-1.4	12.4	-70	-347.1	-81.6	-11.5	-72	8.6	44.2	32.7	66	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	1169.97	301.9	280.5	252.7	238.2	182.7	141.6	127.2	153.1	104.3	65.3	50.2	43.2	36	22.9	31.2	31.7	19.6	144.4	76.2	122.1	66.4	19.5	17.9	-39.9	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	1786.7	222.9	445.5	757.3	465.2	411.9	413.7	359.6	213.5	106.5	32	25.2	77.1	58.6	66.5	54.3	127.4	456	65.5	113	123.1	205.4	45.4	47.7	122	119.5	160.6	180.3	112.7	106.9	60.1	44.1	18.5
balance-sheet.row.total-non-current-assets	31404.69	7778.7	7877.5	7698.8	5963.5	5103.3	4965.6	4547.9	4558.5	4499.7	4136.7	3585.3	2659.9	1694.9	1506.3	1282.8	1314	1359.7	1302.2	1319.4	1156.1	1066.2	881.1	764.5	793.7	734.5	747.9	703	575.7	500	367	279.2	152.8
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	100760.61	25044.8	24864.8	22371.9	20590.8	17976.5	17437.3	15897.7	10529.3	8077.5	7302.6	6566	5633.8	4602.9	3662	3124.4	2923.8	2945.7	2458.4	2163.6	2201.9	2129.3	1856.4	1676.2	1588.3	1557.8	1560.9	1510.1	1316.7	1109.8	870.1	797.3	594.3
balance-sheet.row.account-payables	6268.61	763.8	1862	1817.3	1624.8	1263.1	1354.9	1163.5	911.5	935.8	951.4	811.7	595.4	207.9	164.7	182.4	159.5	181.6	185.3	159.3	258.2	134.1	228.4	112.1	141.8	96.4	94.4	125.3	93.3	121.3	43.4	53.7	31.7
balance-sheet.row.short-term-debt	9312.59	3414.3	1632.7	2052.3	1559.5	1360.8	1500.4	0.4	0.4	650.4	376.3	491.5	536.6	251.7	277.9	219	531.1	420.4	580.7	594.1	448.8	492.5	183.2	301.6	173.8	139.5	199.5	108.4	230.7	200.8	109.7	102.3	212.3
balance-sheet.row.tax-payables	920.92	181.6	255.5	160.4	248.8	223.3	245.1	1045.8	292.3	130	33.2	89.4	96.7	90.2	83.8	77.6	77.1	68.6	26.5	8	15.5	43.4	45.1	40.7	21.1	36.7	-0.3	14.9	26.2	16.2	15.8	4.1	2.7
balance-sheet.row.long-term-debt-total	7547.76	1612.8	1986.1	642.1	370.4	0	0.7	0.7	0.7	0.7	466.5	549.9	0.7	1.2	66.8	90.7	100.7	70.7	110.7	0.7	89.6	25	71.5	0.6	50.5	55.1	19.8	83.4	82.2	0.3	0.1	2.5	15.7
Deferred Revenue Non Current	1162.85	269.4	273.2	258.9	276.1	246.7	262.7	225.8	95	99.6	77.3	0	74.2	67.1	28.6	27.7	19.3	15.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	799.89	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	3949.21	3771	3675.8	13.5	6.3	151.8	2269.2	115.3	428.7	65.3	356	61.8	438	439	21.1	16.5	12.8	5	7.6	8.5	15.3	18.7	18.3	24.4	15.8	15.3	21	10.3	12.3	0.7	3	1.6	10
balance-sheet.row.total-non-current-liabilities	9610.15	1921.6	2531.9	1135.8	867.8	407.6	317.9	253.1	113	112.7	551	631.8	77.4	70.2	97.6	121.7	121.9	118.3	132.8	17.3	110.3	58.3	82.4	0.6	50.5	58.9	32.5	84.7	82.2	0.3	0.1	2.5	15.7
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	36.35	9	11.6	5.3	10.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	41566.98	10008.8	9928.6	8060.9	6950.7	5701.2	5687.5	4664.1	3423.6	3267.6	3220.2	2961.5	2453.6	1591.3	1022.8	898.9	1089.3	954.8	1079.9	925.2	1030	954.7	727.1	639.4	581.2	584	494.5	473.4	547.1	447.5	246.6	250.6	318.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	3721.69	923.9	935.6	937.9	944.8	934.8	719.1	553.2	425.7	396.9	295.7	295.7	295.7	295.7	295.7	295.7	306	306	306	306	306	306	306	306	306	306	306	306	199.4	199.4	184.4	162.9	113.1
balance-sheet.row.retained-earnings	43069.29	10908.2	10437.6	9716.4	8937.3	8419	8012.6	8028.3	3812.4	3267	2708	2352.1	2023.3	1740.6	1446.7	1114.7	711.2	817.3	267.8	153.5	118.5	70.8	16.2	19	50.8	39.2	97.6	84.3	58.4	5.5	115.7	79.5	59.2
balance-sheet.row.accumulated-other-comprehensive-income-loss	7190.87	1180.4	1136.4	982.7	1018.6	721.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	1722.63	1029.9	1366.4	1366.8	1206.5	1091.1	1920.3	2191.2	2267.8	682.3	692.8	696.8	688.9	806.8	775	738.7	761.3	819.3	765.7	744.8	715.2	667.7	627.2	594	559.2	556.8	615	603.8	480.7	452.2	318.2	304.3	103.2
balance-sheet.row.total-stockholders-equity	55704.48	14042.5	13876	13003.8	12107.2	11166.8	10652	10772.7	6506	4346.3	3696.5	3344.6	3008	2843.2	2517.4	2149.1	1778.5	1942.7	1339.5	1204.4	1139.7	1044.6	949.4	919	916	902	1018.6	994.2	738.5	657.1	618.3	546.7	275.6
balance-sheet.row.total-liabilities-and-stockholders-equity	100760.61	25044.8	24864.8	22371.9	20590.8	17976.5	17437.3	15897.7	10529.3	8077.5	7302.6	6566	5633.8	4602.9	3662	3124.4	2923.8	2945.7	2458.4	2163.6	2201.9	2129.3	1856.4	1676.2	1588.3	1557.8	1560.9	1510.1	1316.7	1109.8	870.1	797.3	594.3
balance-sheet.row.minority-interest	3219.79	724.2	1060.2	1307.3	1532.8	1108.5	1097.9	460.9	599.7	463.6	385.9	259.9	172.1	168.4	121.7	76.4	56	48.3	39	34.1	32.2	130	180	117.8	91.1	71.9	47.8	42.5	31.1	5.2	5.2	0	0
balance-sheet.row.total-equity	58924.27	14766.7	14936.3	14311	13640.1	12275.2	11749.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	100760.61	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	6824.71	1762.7	1738.2	1694.9	988.1	651.2	595.8	286.1	238.4	248.5	179.2	133.8	131.6	127.8	56.5	61.3	51.8	101	55.5	59	43.1	69.1	61.1	48.7	76.7	41.6	36.3	0	1.3	5.7	11.2	41.7	0
balance-sheet.row.total-debt	16869.38	5036.1	3618.7	2694.4	1929.9	1360.8	1501.1	1.1	1.1	651.1	842.8	1041.4	537.3	252.9	344.7	309.7	631.8	491.1	691.4	594.8	538.4	517.5	254.7	302.2	224.3	194.7	219.3	191.8	312.9	201.1	109.9	104.8	227.9
balance-sheet.row.net-debt	-26792.9	-6289.6	-6792.6	-6452	-8023.8	-7494.6	-7086.8	-7414.7	-2060.8	-147.2	127.1	280.3	-684.1	-1194.8	-519.3	-278.8	91.6	208.4	407.5	465.3	234.9	93.4	-40.6	69.4	114.3	42.1	174.4	115.5	223.9	164	59	53.4	147.8

Nakit Akış Tablosu

Livzon Pharmaceutical Group Inc.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek 0.404 şeklinde bir değişim sergilemiştir. Şirket kısa süre önce -23.55 ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla -1.241 oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden -777111530.000 tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre -0.368 değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan 866.38, -23.6 ve -531.84 'i kaydetti. Şirketin finansman faaliyetleri 0.000 net nakit kullanımına yol açmış ve bir önceki yıla göre 0.000 farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için -1487.56 ayırmıştır. Aynı zamanda, -407.99 olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1979.57	1953.7	1955.5	1952.1	2131.3	1461.6	1181.7	4487.7	829.9	659.6	553.6	524	475.2	387.8	452.5	513.8	72.9	523.4	149.3	116.3	134.7	121.5	86.3	74.7	25.9	9	40.8
cash-flows.row.depreciation-and-amortization	-39.81	866.4	652.3	445.3	394.3	384.6	364.1	359.2	362.1	310.9	247.1	168.9	152	141	120.9	126.9	131.9	122.5	105.6	96.8	75.8	83.6	71.4	76.1	51.7	39.3	32.1
cash-flows.row.deferred-income-tax	-369.4	-13.4	2.4	15.5	-39.4	-21	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	113.77	-1716.6	47.3	32.7	31.4	16.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	208.59	16.2	-121.6	-653.2	-406.6	-197.1	-371.5	823.2	-64	-203	-180.2	-308.4	-84	111.2	52.2	-144.2	-133.3	-105.2	-30.7	-49.2	-15.9	56.1	-4.2	-75.7	-44	119.8	-77.3
cash-flows.row.account-receivables	466.29	466.3	-660.5	-664.7	-491.9	-81.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-334.42	-334.4	-498.6	-232	-400.3	-108.3	-97.1	-44.9	-182.1	-196.6	-270.8	-135.3	-140.1	14.6	-116.7	-1.2	-32.6	-51.7	-53.6	-24.8	10.6	11.3	-5.7	23.1	-10.5	11.6	2.8
cash-flows.row.account-payables	0	-115.7	1035	228	525	13.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	76.73	0	2.4	15.5	-39.4	-21	-274.4	868.1	118.1	-6.4	90.6	-173.1	56.1	96.5	168.8	-143	-100.7	-53.5	22.9	-24.5	-26.4	44.8	1.5	-98.8	-33.5	108.3	-80.1
cash-flows.row.other-non-cash-items	2098.71	2288	236.7	109.9	49.6	122.4	93.3	-4354.2	151.2	160.3	96.9	55.5	50.8	68.3	7.8	-1.6	273.7	-292.1	2.2	-2.7	-13.2	38.9	60.1	80.1	4.9	78.1	-13.9
cash-flows.row.net-cash-provided-by-operating-activities	3954.38	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-829.66	-820.5	-940.1	-1309.1	-647	-398	-474.5	-294.2	-368.5	-477.1	-665.5	-920	-762.3	-348.8	-337	-131.4	-75.5	-91.3	-180.4	-256.7	-146.5	-103.6	-103.6	-81.5	-61.5	-73.4	-31.7
cash-flows.row.acquisitions-net	41.9	68.5	3	3.3	5.3	1.9	24.7	4479.9	78	7	2.8	0.2	762.6	349.5	344.6	-7	-71.3	95.5	224.8	10	11.8	8	2.4	9	0	7.9	0.7
cash-flows.row.purchases-of-investments	-774.52	-473.2	-399.2	-786	-129.2	-126.1	-556	-188.7	-672.6	-80.8	-93.3	-0.5	-151.5	-75.3	-2.4	0.7	-18.2	-430.4	-447.8	-152.5	-281.6	-268.4	-23.3	-63.9	-33.9	-32.1	-2.6
cash-flows.row.sales-maturities-of-investments	451.25	471.6	130.7	208.7	273.3	136.1	37	674.3	1.2	0.5	14.3	47.4	18	1.2	1.2	146.7	133.8	503.1	447.8	178.2	251.3	96.5	15.1	20.4	0.3	10.1	16.2
cash-flows.row.other-investing-activites	-27.71	-23.6	-24.2	6.2	29.7	70.1	-52.2	1.3	18.6	-7.9	3.6	-1.7	-762.3	-348.8	-337	5	11.2	-91.3	-180.4	-0.5	0	-0.6	0.8	0.6	-0.6	-0.2	1.8
cash-flows.row.net-cash-used-for-investing-activites	-1138.74	-777.1	-1229.9	-1876.9	-467.8	-316	-1020.8	4672.7	-943.2	-558.4	-738	-874.6	-895.5	-422.3	-330.5	14	-20	-14.4	-136.2	-221.5	-165	-268	-108.5	-115.5	-95.7	-87.8	-15.6
cash-flows.row.debt-repayment	-2442.86	-531.8	-2804.8	-2033.6	-1829.8	-1650	-300	-350	-1510	-1242	-1167.4	-1235.2	-620.8	-311.6	-414.6	-929.4	-1166.7	-1044.8	-1100.5	-821.7	-1024.5	-518.3	-605.8	-262.4	-285.2	-295.1	-304.1
cash-flows.row.common-stock-issued	-23.55	-23.5	56	238.2	250.1	0	637.6	15	1518.3	298.9	98	51.5	0	0	9.8	0.4	0	0	0	0	0	0	34.1	0.1	5.7	0	0
cash-flows.row.common-stock-repurchased	-346.15	-346.2	-56	-238.2	-250.1	0	0	-64	-352.4	414.6	1149.8	1295.5	0	0	436.2	594.5	0	0	0	0	0	0	536.4	340.4	308.6	0	0
cash-flows.row.dividends-paid	-1581.51	-1487.6	-1299.9	-1257.4	-1100	-868.5	-1120.7	-216.3	-231.1	-83.4	-199.3	-192.3	-185.3	-37.1	-55.9	-51.7	-192.6	-33.6	-42.8	-63.8	-42.8	-76.8	-44.2	-26	-22	-39.2	-22.6
cash-flows.row.other-financing-activites	2322.69	-408	3384.4	2475.9	2411.8	1337.4	1640.5	32.1	1514	297.1	98	88.2	853.2	652.8	10.4	-104.8	1295.9	845.4	1207.5	773.6	930.1	692.1	36.6	0.4	7.7	285	329.1
cash-flows.row.net-cash-used-provided-by-financing-activities	-2665.47	-1733.4	-720.4	-815	-518	-1181.1	857.4	-583.1	938.8	-314.9	-20.9	7.8	47.2	304.1	-14.1	-490.9	-63.4	-233	64.2	-111.9	-137.2	97	-43	52.5	14.7	-49.2	2.4
cash-flows.row.effect-of-forex-changes-on-cash	43.17	20	124.9	-37.2	-77	20.4	58.5	-66.4	20.1	3.5	-0.3	-0.9	0.8	-2.3	-2.5	0.2	-2.8	-3.7	-0.2	-1.7	0.1	-0.1	0	0	0	0	0
cash-flows.row.net-change-in-cash	176.59	914.4	947.3	-826.7	1097.9	290.5	1162.7	5339.1	1294.8	58	-41.8	-427.7	-253.5	587.7	286.2	18.1	259	-2.6	154.4	-174	-120.6	128.8	62.1	92.1	-42.5	109.2	-31.4
cash-flows.row.cash-at-end-of-period	42594.48	11325.7	10072.6	9125.3	9952	8854.2	8563.7	7401	2061.9	767.1	709.1	750.9	1178.6	1432.2	844.5	558.3	540.2	281.2	283.9	129.5	303.5	424.1	295.3	232.8	110	152.5	44.9
cash-flows.row.cash-at-beginning-of-period	42417.89	10411.3	9125.3	9952	8854.2	8563.7	7401	2061.9	767.1	709.1	750.9	1178.6	1432.2	844.5	558.3	540.2	281.2	283.9	129.5	303.5	424.1	295.3	233.1	140.7	152.5	43.3	76.3
cash-flows.row.operating-cash-flow	3954.38	3394.2	2772.7	1902.3	2160.8	1767.2	1267.6	1315.9	1279.2	927.8	717.4	440	594	708.2	633.3	494.9	345.2	248.6	226.5	161.1	181.5	300	213.6	155.1	38.5	246.2	-18.2
cash-flows.row.capital-expenditure	-829.66	-820.5	-940.1	-1309.1	-647	-398	-474.5	-294.2	-368.5	-477.1	-665.5	-920	-762.3	-348.8	-337	-131.4	-75.5	-91.3	-180.4	-256.7	-146.5	-103.6	-103.6	-81.5	-61.5	-73.4	-31.7
cash-flows.row.free-cash-flow	3124.72	2573.8	1832.5	593.2	1513.8	1369.2	793.1	1021.7	910.8	450.7	51.9	-480	-168.3	359.4	296.3	363.5	269.7	157.3	46	-95.6	35	196.5	110	73.7	-23	172.8	-50

Gelir Tablosu Satırı

Livzon Pharmaceutical Group Inc.'nın geliri bir önceki döneme göre -0.028% oranında bir değişim gösterdi. Şirketin 000513.SZ brüt kârı 7356.6 olarak raporlanmıştır. Şirketin işletme giderleri 5434.76 olup, geçen yıla göre -8.412% değişim göstermiştir. Amortisman ve itfa giderleri 866.38, yani -0.065% son hesap dönemine göre değişimdir. İşletme giderleri 5434.76 olarak raporlanmıştır ve yıldan yıla -8.412% değişim göstermektedir. Satış ve pazarlama giderleri 0, bir önceki yıla göre 0.000% değişimdir. Son rakamlara göre FAVÖK 0 olup, yıldan yıla -0.182% büyümeyi temsil etmektedir. Faaliyet geliri 1921.84 olup, bir önceki yıla göre -0.182% değişim göstermektedir. Net gelirdeki değişim 0.023%'dir. Geçen yılın net geliri 1953.65 idi.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1991
income-statement-row.row.total-revenue	12223.18	12278.5	12629.6	12063.9	10520.4	9384.7	8860.7	8531	7651.8	6620.5	5544.2	4618.7	3943.5	3162.9	2726.7	2595.8	2058.6	1748.1	1510.1	1626.1	1554.8	1811.9	1601.2	1395.8	1178.6	1133.8	899	822.2	721.1	682.7	600.1	699.7	695.9
income-statement-row.row.cost-of-revenue	4437.01	4921.9	4461.3	4253.1	3673.7	3391.7	3359.7	3083.1	2747.8	2575.3	2142.9	1694.6	1569.7	1397.9	1286.5	1232	1116.3	973.6	806	906.2	791.5	914.6	894.5	741.4	634.8	622.8	580.3	526.1	475.6	466.5	423.9	571.8	578.5
income-statement-row.row.gross-profit	7786.18	7356.6	8168.3	7810.8	6846.7	5993	5501	5447.9	4904	4045.2	3401.3	2924.1	2373.8	1765	1440.2	1363.9	942.3	774.5	704	719.9	763.3	897.3	706.7	654.4	543.8	511	318.8	296.1	245.6	216.2	176.1	127.9	117.4
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	1201.39	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	697.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	3509.36	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-220.47	-291	-36.9	351.7	318.2	320.4	142.4	68.6	130.2	121.1	68.9	38.6	42.6	33.6	18.1	7.4	7.9	6.9	-28.6	3.1	2.7	4.6	13.1	7.5	3.4	20.7	56	33	29.4	16.2	9.4	1.4	-0.6
income-statement-row.row.operating-expenses	5579.94	5434.8	5933.9	5623.1	4531.7	4408	4396	4236.2	3915.3	3229	2741.9	2306.6	1847.2	1309.3	922.8	788.7	579.5	463.5	546.8	588	633.2	755.7	572.2	546.7	477.4	511.4	306.1	246.3	181.5	139.2	85.3	52.3	41.3
income-statement-row.row.cost-and-expenses	10016.94	10356.7	10395.2	9876.2	8205.4	7799.7	7755.6	7319.3	6663.1	5804.3	4884.8	4001.2	3416.9	2707.2	2209.3	2020.7	1695.8	1437.2	1352.8	1494.2	1424.7	1670.3	1466.7	1288.1	1112.2	1134.2	886.3	772.4	657.1	605.7	509.2	624.1	619.8
income-statement-row.row.interest-income	-408.07	-368.2	-315.1	162.2	175.6	226.4	236.2	78.1	9	10.5	13.7	21.9	40.1	42	10.4	5.1	7.5	3.7	2.9	2.5	2.9	7.7	3.5	9.5	3.7	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	102.25	102.1	97.5	84	25.3	7.3	16.8	3.1	27	31.3	26.9	9.1	17.2	22.1	11	17.3	43.9	30.4	33.6	18.7	11.4	10	21.1	14.1	10.3	7.9	12.2	18.3	14.5	18.7	0.9	15.7	16.1
income-statement-row.row.selling-and-marketing-expenses	3509.36	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	123.03	402.4	-20	-21.3	-11	-2.3	311.7	4513.2	16.4	-8.3	-7.4	11.4	33.7	7.4	16.2	14.3	-257.2	309	22.4	-2.6	19	10.4	-38.2	-19.4	-34.6	16	48.3	19.8	32.9	10.7	19.8	-13.6	-16.7
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-220.47	-291	-36.9	351.7	318.2	320.4	142.4	68.6	130.2	121.1	68.9	38.6	42.6	33.6	18.1	7.4	7.9	6.9	-28.6	3.1	2.7	4.6	13.1	7.5	3.4	20.7	56	33	29.4	16.2	9.4	1.4	-0.6
income-statement-row.row.total-operating-expenses	123.03	402.4	-20	-21.3	-11	-2.3	311.7	4513.2	16.4	-8.3	-7.4	11.4	33.7	7.4	16.2	14.3	-257.2	309	22.4	-2.6	19	10.4	-38.2	-19.4	-34.6	16	48.3	19.8	32.9	10.7	19.8	-13.6	-16.7
income-statement-row.row.interest-expense	102.25	102.1	97.5	84	25.3	7.3	16.8	3.1	27	31.3	26.9	9.1	17.2	22.1	11	17.3	43.9	30.4	33.6	18.7	11.4	10	21.1	14.1	10.3	7.9	12.2	18.3	14.5	18.7	0.9	15.7	16.1
income-statement-row.row.depreciation-and-amortization	372.3	866.4	926.6	588.1	474.4	445.9	364.1	359.2	362.1	310.9	247.1	168.9	152	141	120.9	126.9	131.9	122.5	105.6	96.8	75.8	83.6	71.4	76.1	51.7	39.3	32.1	12.2	-3.5	3.4	-15.5	14.5	16.1
income-statement-row.row.ebitda-caps	2729.85	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	2357.55	1921.8	2350.6	2267	2500.4	1729.9	1274.5	5657.8	876.5	692.8	584.5	590.6	518.8	429.7	516.4	583.3	99.6	613.8	218.4	131.7	157.6	158.8	113.7	107.9	35.3	-2.4	9	37.6	67.5	73.6	106.3	61.1	60
income-statement-row.row.income-before-tax	2480.58	2324.2	2330.6	2245.7	2489.4	1727.5	1416.7	5724.9	1005.1	807.9	652	628.9	560.3	463.2	533.7	589.4	105.7	620	184.7	132.1	154.7	157.7	111.6	101.9	35.3	17	63	70.1	96.9	88.8	113.2	62.2	59.4
income-statement-row.row.income-tax-expense	491.85	485.1	375	293.6	358.1	266	235	1237.2	175.1	148.4	98.4	105	85.1	75.4	81.2	75.6	32.7	96.6	35.4	15.8	19.9	36.2	25.3	27.2	9.4	7.9	15.9	15.5	10.3	7.7	10.3	3	1.6
income-statement-row.row.net-income	1979.57	1953.7	1909.4	1775.7	1714.9	1302.9	1082.2	4428.7	784.4	622.6	516	487.5	441.7	359.4	418.2	481.6	52.1	508.5	139.1	107.9	124.1	92.2	61.9	50.4	10.4	1.6	40.8	43.2	81.4	80.2	101.1	59.2	57.8